Proximal sciatic axotomy does not inhibit the induction of neurofilamentous inclusions following intracisternal aluminum chloride exposure

Journal of Neuropathology and Experimental Neurology

Volumn 55, Issue 4, 1996, Pages 419-423

  Strong, Michael J ^a,b   Gaytan Garcia, Silvia ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Aluminum; Axotomy; Motor neuron disease; Neurofilament

Indexed keywords

ALUMINUM CHLORIDE; NEUROFILAMENT PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CERVICAL SPINAL CORD; DOSE RESPONSE; EXPOSURE; LUMBOSACRAL PLEXUS; MOTONEURON; NERVE FIBER TRANSECTION; NEUROFILAMENT; NONHUMAN; PARALYSIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; RABBIT; RNA TRANSCRIPTION; SCIATIC NERVE; STOICHIOMETRY;

EID: 0029998946     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199604000-00004     Document Type: Article

References (38)

1. Strong MJ. Aluminum-induced neurodegeneration with special reference to amyotrophic lateral sclerosis and dialysis encephalopathy. Rev Biochem Toxicol 1994;11:75-115
2. Parhad IM, Krekoski CA, Mathew A, Tran PM. Neuronal gene expression in aluminum myelopathy. Cell Mol Neurobiol 1989;9: 123-38
3. Muma NA, Troncoso JC, Hoffman PN, Koo EH, Price DL. Aluminum neurotoxicity: Altered expression of cytoskeletal genes. Mol Brain Res 1988;3:115-22
4. Katsetos CD, Savory J, Herman MM, et al. Neuronal cytoskeletal lesions induced in the CNS by intraventricular and intravenous aluminium maltol in rabbits. Neuropathol Appl Neurobiol 1990;16: 511-28
5. Savory J, Herman MM, Hundley JC, et al. Quantitative studies on aluminum deposition and its effects on neurofilament protein expression and phosphorylation, following intraventricular administration of aluminum maltolate to adult rabbits. NeuroToxicology 1993;14:9-12
6. Strong MJ, Mao K, Nerurkar VR, Wakayama I, Yanagihara R, Garruto RM. Dose-dependent selective suppression of light (NFL) and medium (NFM) but not high (NFH) molecular weight neurofilament gene transcription in acute aluminum neurotoxicity. Mol Cell Neurosci 1994;5:319-26
7. Xu Z, Cork LC, Griffin JW, Cleveland DW. Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease. Cell 1993;73:23-33
8. Côte F, Collard J-F, Julien J-P. Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: A mouse model of amyotrophic lateral sclerosis. Cell 1993;73:35-46
9. Julien J-P, Côte F, Collard J-F. Mice overexpressing the human neurofilament heavy gene as a model of ALS. Neurobiol Aging 1995;16:487-92
10. Strong MJ, Jakowec DM. 200 kDa and 160 kDa neurofilament protein phosphatase resistance following in vivo aluminum chloride exposure. NeuroToxicology 1994;15:799-808
11. 3 in New Zealand white rabbits. Acta Neuropathol 1995;90:57-67
12. Gaytan-Garcia S, Kim H, Strong MJ Spinal motor neuroaxonal spheroids in chronic aluminum neurotoxicity contain phosphataseresistant high molecular weight neurofilament (NFH). Toxicology 1996:(in press)
13. Hisanaga S, Yasugawa S, Yamakawa T, et al. Dephosphorylation of microtubule-binding sites at the neurofilament-H tail domain by alkaline, acid, and protein phosphatases. J Biochem 1993;113:705-9
14. Wong J, Oblinger MM. Changes in neurofilament gene expression occur after axotomy of dorsal root ganglion neurons: An in situ hybridization study. Metab Brain Dis 1987;2:291-303
15. Schwartz ML, Shneidman PS, Bruce J, Schlaepfer WW. Actinomycin prevents the destabilization of neurofilament mRNA in primary sensory neurons. J Biol Chem 1992;267:24596-24600
16. Tetzlaff W, Bisby MA, Kreutzberg GW. Changes in the cytoskeletal proteins in the rat facial nucleus following axotomy. J Neurosci 1988;8:3181-89
17. Goldstein ME, Weiss SR, Lazzarini RA, Shneidman PS, Lees JF, Schlaepfer WW. mRNA levels of all three neurofilament proteins decline following nerve transection. Mol Brain Res 1988;3:287-92
18. Hoffman PN. Pollock SC, Striph GG. Altered gene expression after optic nerve transection: Reduced neurofilament expression as a general response to axonal injury. Exp Neurol 1993;119:32-36
19. Muma NA, Hoffman PN, Slunt HH, Applegate MD, Lieberburg I, Price DL. Alterations in levels of mRNAs coding for neurofilament protein subunits during regeneration. Exp Neurol 1990;107:230-35
20. Hoffman PN, Cleveland DW. Neurofilament and tubulin expression recapitulates the develomental program during axonal regeneration: Induction of a specific b-tubulin isotype. Proc Natl Acad Sci USA 1988;85:4530-33
21. Hoffman PN. Expression of GAP-43, a rapidly transported growth-associated protein and class II beta tubulin, a slowly transported cytoskeletal protein, are coordinated in regenerating neurons. J Neurosci 1989;9:893-97
22. Neumann D, Scherson T, Ginzburg I, Littauer UZ, Schwartz M. Regulation of mRNA levels for microtubule proteins during nerve regeneration. FEBS Letts 1983;162:270-76
23. Burrell HR, Heacock AM, Water RD, Agranoff BW. Increased tubulin messenger RNA in the goldfish retina during optic nerve regeneration. Brain Res 1979;168:628-32
24. McKerracher L, Essagian C, Aguayo AJ. Temporal changes in b-tubulin and neurofilament mRNA levels after transection of adult rat retinal ganglion cell axons in the optic nerve. J Neurosci 1993;13:2617-26
25. Barron KD, Marciano FF, Amundson R, Mankes R. Perineuronal glial response after axotomy of central and peripheral axons. A comparison. Brain Res 1990;523:219-29
26. Thanos S, Mey J, Wild M. Treatment of the adult retina with microglia-suppressing factors retards axotomy-induced neuronal degradation and enhances axonal regeneration in vivo and in vitro. J Neurosci 1993;13:455-66
27. Thanos S. The relationship of microglial cells to dying neurons during natural neuronal cell death and axotomy-induced degeneration of the rat retina. Eur J Neurosci 1991;3:1189-1207
28. Svensson M, Aldskogius H. Regeneration of hypoglossal nerve axons following blockade of the axotmy-induced microglial cell reaction in the rat. Eur J Neurosci 1993;5:85-94
29. Righi M, Mori L, De Libero G, et al. Monokine production by microglial cell clones. Eur J Immunol 1989;19:1443-48
30. Frei K, Malipiero UV, Leist TP, Zinkernagel RM, Schwab ME, Fontana A. On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases. Eur J Immunol 1989;19:689-94
31. Frei K, Siepl C, Groscurth P, Bodmer S, Schwerdel C, Fontana A. Antigen presentation and tumor cytotoxicity by interferon-gamma-treated microglial cells. Eur J Immunol 1987;17:1271-78
32. Sawada M, Kondo N, Suzumura A, Marunouchi T. Production of tumor necrosis factor-alpha by microglia and astrocytes in culture. Brain Res 1989;491:394-97
33. Giulian D, Baker TJ, Shin L-CN, Lachman LB. Interleukin 1 of the central nervous system is produced by ameboid microglia. J Exp Med 1986;164:594-604
34. Hetier E, Ayala J, Denefle P, et al. Brain macrophages synthesize interleukin-1 and interleukin-1 mRNAs in vitro. J Neurosci Res 1988;21:391-97
35. Giulian D, Lachman LB. Interleukin-1 stimulation of astroglial proliferation after brain injury. Science 1985;228:497-99
36. Giulian D, Chen J, Ingernan JE, George JK, Noponen M. The role of mononuclear phagocytes in wound healing after traumatic injury to adult mammalian brain. J Neurosci 1989;9:4416-29
37. Gehrmann J, Monaco S, Kreutzberg GW. Spinal cord microglial cells and DRG satellite cells rapidly respond to transection of the rat sciatic nerve. Restor Neurol Neurosci 1991;2:181-98
38. Nixon RA, Clarke JF, Logvinenko KB, Tan MKH, Hoult M, Grynspan F. Aluminum inhibits calpain-mediated proteolysis and induces human neurofilament proteins to form protease-resistant high molecular weight complexes. J Neurochem 1990;55:1950-59